[go: up one dir, main page]

SE8801708D0 - NEW USE OF DOPAMINE RECEPTOR AGONISTS - Google Patents

NEW USE OF DOPAMINE RECEPTOR AGONISTS

Info

Publication number
SE8801708D0
SE8801708D0 SE8801708A SE8801708A SE8801708D0 SE 8801708 D0 SE8801708 D0 SE 8801708D0 SE 8801708 A SE8801708 A SE 8801708A SE 8801708 A SE8801708 A SE 8801708A SE 8801708 D0 SE8801708 D0 SE 8801708D0
Authority
SE
Sweden
Prior art keywords
receptor agonists
dopamine receptor
new use
lergotrile
lisuride
Prior art date
Application number
SE8801708A
Other languages
Swedish (sv)
Other versions
SE8801708L (en
Inventor
P S Muller
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8801708D0 publication Critical patent/SE8801708D0/en
Publication of SE8801708L publication Critical patent/SE8801708L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Direct dopamine receptor agonists are used in the preparation of medicaments for the treatment of nicotine addiction. Suitable active agents are pergolide, lisuride, lergotrile and, particularly, bromocriptine.
SE8801708A 1987-05-07 1988-05-05 NEW USE OF DOPAMN RECEPTOR AGONISTS SE8801708L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4775387A 1987-05-07 1987-05-07

Publications (2)

Publication Number Publication Date
SE8801708D0 true SE8801708D0 (en) 1988-05-05
SE8801708L SE8801708L (en) 1988-11-08

Family

ID=21950776

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801708A SE8801708L (en) 1987-05-07 1988-05-05 NEW USE OF DOPAMN RECEPTOR AGONISTS

Country Status (13)

Country Link
JP (1) JPS63287723A (en)
KR (1) KR880013556A (en)
AU (1) AU622614B2 (en)
CH (1) CH675834A5 (en)
DE (1) DE3814521A1 (en)
DK (1) DK245388A (en)
FR (1) FR2614789B1 (en)
GB (1) GB2204240B (en)
IT (1) IT1219564B (en)
NL (1) NL8801171A (en)
PH (1) PH25495A (en)
SE (1) SE8801708L (en)
ZA (1) ZA883237B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
DE19626621A1 (en) * 1996-07-02 1998-01-08 Hexal Ag Plaster for transdermal application of pergolide
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861128B (en) * 1985-05-06 1986-08-26 Sandoz Ag New use of dopamine agonists
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN

Also Published As

Publication number Publication date
GB2204240A (en) 1988-11-09
KR880013556A (en) 1988-12-21
GB8810509D0 (en) 1988-06-08
DK245388A (en) 1988-11-08
GB2204240B (en) 1991-04-24
FR2614789A1 (en) 1988-11-10
NL8801171A (en) 1988-12-01
AU622614B2 (en) 1992-04-16
CH675834A5 (en) 1990-11-15
PH25495A (en) 1991-07-24
DK245388D0 (en) 1988-05-05
SE8801708L (en) 1988-11-08
JPS63287723A (en) 1988-11-24
DE3814521A1 (en) 1988-11-17
ZA883237B (en) 1990-01-31
IT8847906A0 (en) 1988-05-03
IT1219564B (en) 1990-05-18
FR2614789B1 (en) 1991-10-18
AU1560588A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
NO910187D0 (en) PROCEDURE FOR THE PREPARATION OF INDOLS-SUBSTITUTED, HETEROAROMATIC FEMRING COMPOUNDS.
DE69925024D1 (en) USE OF EPH RECEPTOR ANTAGONISTS AND AGONISTS FOR THE TREATMENT OF VASCULAR DISEASES
DK59182A (en) PHARMACEUTICAL AGENTS WITH CONTINUOUS RELEASE
IT1219906B (en) THERAPEUTIC USE OF DOPAMINERGIC RECEPTOR AGONISTS
DE69414398D1 (en) HETEROCYCLIC NEUROKININ ANTAGONISTS
AR016217A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A DEVICE MODULATOR OF A NICOTINIC RECEIVING AGONIST, METHOD FOR THE TREATMENT OF AN ASSOCIATED DISORDER WITH A REDUCED NICOTINE TRANSMISSION, A METHOD FOR IDENTIFYING A NICOTINIC NICOTINIS MODEL REPECTOR AGENT,
SI1202727T1 (en)
SE8801708D0 (en) NEW USE OF DOPAMINE RECEPTOR AGONISTS
SE8400445D0 (en) NOVEL PHARMACEUTICAL ACTIVE 1,2,3,4,4A, 5,10,10A-OCTAHYDROBENZO (G) QUINOLINE DERIVATIVES, THEIR PRODUCTION AND USE
IT1203782B (en) THERAPEUTIC USE OF DOPAMINERGIC AGONISTS
DE3882141D1 (en) HOLDER FOR SUCTION INSERTS.
ES2052670T3 (en) USE OF 2-PIRIMIDINYL-1-PIPERAZINE DERIVATIVES.
ES2098263T3 (en) 8-ALPHA-ACILAMINO-ERGOLINS, THEIR PREPARATION AND THEIR USE AS MEDICINES.
IT8948215A0 (en) THERAPEUTIC USE OF BENZO (G)QUINOLINE DERIVATIVES FOR THE TREATMENT OF NICOTINE ADDICTION
NL172616B (en) PROCESS FOR PREPARING STABLE SOLUTIONS FOR ORAL USE OF HYDROGENATED MOTHER-CHALK CALOIDES.
EP0417637A3 (en) Use of dopamine autoreceptor agonists in the treatment of drug dependency
ES469908A1 (en) Oral administration of Salinomycin to pigs
NO172114C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED BIFENYLES
JPS5572193A (en) 9*100dihydroo4hhbenzo*4*5*cycloheptaa *1*22b*thiophenee4*99imine
NL7902958A (en) PROCEDURE FOR PREPARING TETRAHYDROALSTONIN DERIVATIVES AND USE AS A THERAPEUTIC AGENT.
BG50187A1 (en) Solid medicinal form on the basis of ergoalkaloid derivatides
NO164544C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HYDRAZONE DERIVATIVES WITH MORPHINAN SKIN.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8801708-2

Effective date: 19911125

Format of ref document f/p: F